OraLiva, Inc. is an innovative medical technology company specializing in the development of advanced early detection diagnostics for oral cancer. By leveraging cutting-edge technology, the company aims to address the critical issue of late-stage cancer diagnosis, enhancing patient outcomes through timely intervention.
Company Values
OraLiva stands out for its clinically validated, AI-linked diagnostic platform that allows for noninvasive and rapid cancer detection directly at the point of care.